PHAXIAM Therapeutics S.A. Weighted Average Shares
PHAXIAM Therapeutics S.A. reported Weighted Average Shares of 3.28 million shares for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2023-09-26
| Period end | Weighted Average Shares 6 month | Weighted Average Shares 6 month as first filed | Weighted Average Shares 12 month |
|---|---|---|---|
| 2023-06-30 | 3.28M shares 6-K · filed 2023-09-26 | ||
| 2022-12-31 | 31.02M shares 20-F · filed 2023-03-28 | ||
| 2022-06-30 | 3.10M shares 6-K · filed 2023-09-26 | 31.02M shares 6-K · filed 2022-09-12 | |
| 2021-12-31 | 23.69M shares 20-F · filed 2023-03-28 | ||
| 2021-06-30 | 22.84M shares 6-K · filed 2022-09-12 | ||
| 2020-12-31 | 18.39M shares 20-F · filed 2023-03-28 | ||
| 2020-06-30 | 17.94M shares 6-K · filed 2021-09-20 | ||
| 2019-12-31 | 17.94M shares 20-F · filed 2022-04-27 | ||
| 2019-06-30 | 17.94M shares 6-K · filed 2020-09-21 | ||
| 2018-12-31 | 17.94M shares 20-F · filed 2021-03-08 | ||
| 2018-06-30 | 17.94M shares 6-K · filed 2019-09-26 | ||
| 2017-12-31 | 11.37M shares 20-F · filed 2020-03-18 | ||
| 2016-12-31 | 7.98M shares 20-F · filed 2019-03-29 | ||
| 2015-12-31 | 6.96M shares 20-F/A · filed 2018-05-23 |